The programme enhances site engagement, removing ‘inefficiencies’ in trials and helping increase technological compliance. Credit: Nuttapong punna/Shutterstock.

Medidata has launched the Medidata Site Insights Program, a comprehensive initiative aimed at expediting life-changing therapy delivery to trial subjects.

This initiative helps to promote open dialogue with clinical trial sites and minimises technological burdens.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

It is said to offer support to the Medidata patient, data, and study experiences to enhance site engagement, remove ‘inefficiencies’ in the trials, and help to increase technological compliance.

Medidata noted that the programme is designed to collaborate with sites in new ways, embedding the site voice in all of its actions and helping to improve the life of the sites and the subjects.

The Medidata Site Insights Program introduces several key initiatives to streamline the clinical trial process.

The Executive Site Advisory Board initiative brings together a select group of industry executives to inform the development of Medidata’s solutions using their therapeutic expertise and subject access.

In addition, the Site User Community has been established via Engage, allowing users to offer ‘real-time feedback’ through polls, discussions, and surveys.

This facilitates the company’s alignment of its products with the changing requirements and challenges faced by sites.

In partnership with the Society of Clinical Research Sites (SCRS), the company will proceed with hosting ‘interactive design studio workshops’ as part of the Site Tech Board initiative.

These workshops combine site users and the company’s product team to refine new technologies, ensuring they are user-friendly and efficient.

Strategic partnerships also play an important role in the company’s approach, as they enable sites to actively contribute to shaping the company’s culture and enhancing the clinical trial ecosystem.

Medidata research site engagement vice-president Robin Douglas said: “By including the site voice in our ongoing discussions, we’re not just streamlining clinical trial processes and enhancing technology but helping our clients to deliver effective treatments to patients sooner.”